SANBIO BV Company Profile

14:00 EST 15th December 2018 | BioPortfolio

Through regular contact with our customers in the Benelux and Germany, Sanbio has been able to offer a wide range of biotechnology and research products in the field of immunology, pathology, molecular biology, cell biology, genetics and clinical chemistry. Many product lines maintain a constant flow of newly developed products, which find their way to universities and research institutes throughout the Benelux.The antibodies supplied under MONOSAN label, are being developed and commercialized either in our own laboratories or in collaboration with some of the leading universities and research institutes throughout Europe. MONOSAN antibodies are also supplied in commercial OEM quantities and formats to international life science and health care companies as raw materials for their own diagnostic products. For additional information see
The company Sanbio has implemented a certified ISO9001-2000 quality system. It is our aim to continuously improve our high standard of quality and support. Any suggestions from your side will be highly appreciated.


P.O.BOX 540
5400 AM


Phone: 31 413-251115
Fax: 31 413 266605

News Articles [15 Associated News Articles listed on BioPortfolio]

SanBio's US-based Phase 1/2a Clinical Trial of SB623 for the Treatment of Chronic Motor Deficit from Ischemic Stroke Was Addressed at an Event Held by California Institute for Regenerative Medicine (CIRM)

The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that the US-based...

SanBio reports positive results from Phase II SB623 trial

SanBio Group has reported positive results from the Phase II STEMTRA trial after it met the primary endpoint. The STEMTRA...Read More... The post SanBio reports positive results from Phase II SB623 tr...

SanBio acquires MSC patent portfolio from Tulane U.

SanBio Co. Ltd. acquired Tulane University's patent portfolio surrounding cell therapies derived from mesenchymal stem cells (MSCs; multipotent cells capable of self-renewing and differentiating into ...

Notice of Personnel Changes to Corporate Officers at SanBio Co., Ltd. and at US Subsidiary SanBio, Inc.

SanBio Co., Ltd. and US subsidiary SanBio, Inc. conducted the following personnel transfers, effective October 1, 2018. 1. Transfer DetailsAkihiro Tsujimura will become a...

SanBio Announces Phase 2 STEMTRA Trial Using SB623 Cells for Treatment of Patients with Traumatic Brain Injury Met Primary Endpoint

The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio Inc.; together, the “Company”) announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of p...

SanBio buys patent portfolio regarding cell medicines derived from MSCs

The patent portfolio includes technology discovered by Aline Betancourt, a researcher at Tulane University. Betancourt’s technology optimizes anti-inflammatory and pro-inflammatory functions of MSCs...

SanBio: Acquisition of a Patent Portfolio Regarding Cell Medicines Derived from Mesenchymal ...


SanBio: Supplementary Information to the Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623

SanBio Co., Ltd. (representative: Keita Mori, headquarters: Chuo-ku, Tokyo; hereinafter SanBio) has agreed to enter into an equity and business alliance with CareNet, Inc. (repres...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [6 Associated Companies listed on BioPortfolio]

SanBio, Inc.

SanBio is a regenerative medicine company with cell based products in various stages of research, development and clinical trials. Its proprietary cell based product, SB623, is be...

SanBio Co., Ltd.

SanBio (TOKYO:4592) is a leading regenerative medical products company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research...


Through regular contact with our customers in the Benelux and Germany, Sanbio has been able to offer a wide range of biotechnology and research products in the field of immunology, pathology, molecula...

SanBio Inc.

SanBio, Co. Ltd.

More Information about "SANBIO BV" on BioPortfolio

We have published hundreds of SANBIO BV news stories on BioPortfolio along with dozens of SANBIO BV Clinical Trials and PubMed Articles about SANBIO BV for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SANBIO BV Companies in our database. You can also find out about relevant SANBIO BV Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Corporate Database Quicklinks

Searches Linking to this Company Record